PSP Research »

Edgewise Therapeutics shares owned by PSP Research

Quarter-by-quarter ownership of Edgewise Therapeutics (EWTX) shares owned by PSP Research from 13F filings

Historical chart of PSP Research investment in Edgewise Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Edgewise Therapeutics held by PSP Research consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Edgewise Therapeutics by PSP Research

Quarter filed Position value Share count Share price at filing
2026-03-31 $205k 6.5k 31.50

More positions owned by PSP Research

Ishares Tr 0-3 Mnth Treasry (SGOV)
Spdr Series Trust State Street Spd (XBI)
Sera Prognostics Class A Com (SERA)
Definium Therapeutics Com Shs (DFTX)
Tyra Biosciences (TYRA)
Ascendis Pharma A/s Sponsored Adr (ASND)
Pharvaris N V (PHVS)
Cytokinetics Com New (CYTK)
Royalty Pharma Shs Class A (RPRX)
Kymera Therapeutics (KYMR)
Halozyme Therapeutics (HALO)
Exelixis (EXEL)
Disc Medicine (IRON)
Ionis Pharmaceuticals (IONS)
Agios Pharmaceuticals (AGIO)

View all positions for PSP Research

Top funds holding Edgewise Therapeutics

OrbiMed Advisors
RA Capital Management
BlackRock
Baker Bros. Advisors
Paradigm Biocapital Advisors
Novo A/S
Braidwell
Vanguard Group
Siren
Perceptive Advisors
Driehaus Capital Management
Cormorant Asset Management
UBS Group
Geode Capital Management
State Street Corporation

View all funds holding Edgewise Therapeutics